Ali Behbahani, Director: Crispr Therapeutics CRSP Planned sale · Filed 09/17

Trade details

Type: Planned sale notice
Stock: Crispr Therapeutics CRSP
Person: Ali BehbahaniDirector
Planned sale date: 26/09/17
Filed: 26/09/17

$780.9K to be sold

Crispr Therapeutics trades, last 26 weeks

What else happened in Crispr Therapeutics around then

Filed or reported within 30 days of the trade day · 08/18~10/17

Ali Behbahani's recent trades

Ali BehbahaniDirector
BuySpyGlass Pharma
Buy
SpyGlass Pharma
SGP
$15M
937,500 sh
$15M
Filed 02/11
Traded 02/09
Ali BehbahaniDirector
SellNeueHealth
Sell
NeueHealth
NEUE
$16.6K
2,455 sh
$16.6K
Filed 25/10/06
Traded 25/10/02
Ali BehbahaniDirector
SellNeueHealth
Sell
NeueHealth
NEUE
$1,890
280 sh
$1,890
Filed 25/10/06
Traded 25/10/02
Ali BehbahaniDirector
SellNeueHealth
Sell
NeueHealth
NEUE
$6,075
900 sh
$6,075
Filed 25/10/06
Traded 25/10/02
Ali BehbahaniDirector
SellNeueHealth
Sell
NeueHealth
NEUE
$1,890
280 sh
$1,890
Filed 25/10/06
Traded 25/10/02